Search Browse Earnings

IGM Biosciences, Inc. — SlamSEC

IGM Biosciences, Inc.

Pharmaceutical Preparations·MOUNTAIN VIEW, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$221.9M

FY 2024

Net Income

-$221.1M

FY 2024

EPS (Diluted)

-$5.32

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$121.2M

FY 2024

Total Debt

—

Net Cash

$121.2M

Enterprise Value

—

Debt / EBITDA

0.5x

FY 2024

EV / EBITDA

—

Employees

—